132 related articles for article (PubMed ID: 21605890)
1. Antiangiogenic activities of bemiparin sodium, enoxaparin sodium, nadroparin calcium and tinzaparin sodium.
Dogan OT; Polat ZA; Karahan O; Epozturk K; Altun A; Akkurt I; Cetin A
Thromb Res; 2011 Oct; 128(4):e29-32. PubMed ID: 21605890
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the antiangiogenic effects of heparin sodium, enoxaparin sodium, and tinzaparin sodium by using chorioallantoic membrane assay.
Katrancioglu N; Karahan O; Kilic AT; Altun A; Katrancioglu O; Polat ZA
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):218-21. PubMed ID: 22343683
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the antiangiogenic behaviors of rivaroxaban and low molecular weight heparins.
Yavuz C; Caliskan A; Karahan O; Yazici S; Guclu O; Demirtas S; Mavitas B
Blood Coagul Fibrinolysis; 2014 Jun; 25(4):303-8. PubMed ID: 24256628
[TBL] [Abstract][Full Text] [Related]
4. Effects of low molecular weight heparins and unfractionated heparin on viability of human umbilical vein endothelial cells.
Guler T; Polat ZA; Yayci E; Atacag T; Cetin A
Arch Gynecol Obstet; 2013 Feb; 287(2):217-22. PubMed ID: 22987257
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacodynamic assessment of the antiangiogenesis activity of heparin and low-molecular-weight heparin fractions: structure-function relationship.
Mousa SA
Clin Appl Thromb Hemost; 2013; 19(1):48-54. PubMed ID: 22327829
[TBL] [Abstract][Full Text] [Related]
6. A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat.
Abdel-Salam OM; Baiuomy AR; Ameen A; Hassan NS
Pharmacol Res; 2005 Jan; 51(1):59-67. PubMed ID: 15519536
[TBL] [Abstract][Full Text] [Related]
7. Influence of low molecular weight heparin preparations on human internal thoracic artery contraction.
Buzun L; Kleszczewski T; Kostrzewska A; Lisowski P; Oleksza P; Jackowski R; Pedzińska A; Hirnle T
Eur J Cardiothorac Surg; 2004 Nov; 26(5):951-5. PubMed ID: 15519188
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacodynamic time-course of bemiparin and enoxaparin in healthy volunteers.
Antonijoan RM; Rico S; Martínez-González J; Borrell M; Valcarcel D; Fontcuberta J; Barbanoj MJ
Int J Clin Pharmacol Ther; 2009 Dec; 47(12):726-32. PubMed ID: 19954711
[TBL] [Abstract][Full Text] [Related]
9. Effects of heparin and low-molecular-weight heparins on bone mechanical properties in rats.
Folwarczna J; Janiec W; Sliwiński L
Thromb Haemost; 2004 Nov; 92(5):940-6. PubMed ID: 15543319
[TBL] [Abstract][Full Text] [Related]
10. Microvascular effects of the low molecular weight heparins in a colorectal xenograft model: an intravital microscopy study.
Debergh I; Pattyn P; Ceelen W
J Surg Res; 2015 Apr; 194(2):488-495. PubMed ID: 25466520
[TBL] [Abstract][Full Text] [Related]
11. In vitro anticoagulation monitoring of low-molecular-weight heparin.
Wang JQ; Shi XB; Yang JG; Hu DY
Chin Med J (Engl); 2009 May; 122(10):1199-202. PubMed ID: 19493471
[TBL] [Abstract][Full Text] [Related]
12. High and low molecular weight heparins do not modify red blood cell aggregability in vitro.
Martínez M; Vaya A; López-Camacho C; Coll-Sangrona E; Mira Y; Aznar J
Clin Hemorheol Microcirc; 2000; 23(1):67-70. PubMed ID: 11214715
[TBL] [Abstract][Full Text] [Related]
13. Can we differentiate the low-molecular-weight heparins?
Turpie AG
Clin Cardiol; 2000 Jan; 23 Suppl 1(Suppl):I4-7. PubMed ID: 10680037
[TBL] [Abstract][Full Text] [Related]
14. Effects of nadroparin, enoxaparin, and unfractionated heparin on endogenous formation of factor Xa and IIa and on thrombelastometry profiles in cord versus adult blood.
Cvirn G; Hoerl G; Tafeit E; Heinl N; Wodrig K; Wagner T; Koestenberger M; Juergens G
Neonatology; 2011; 100(1):23-31. PubMed ID: 21150227
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-molecular-weight heparins on anti-Xa peak levels and adverse reactions in Chinese patients with recurrent spontaneous abortion: a single-center, observational study.
Bai W; Zhang X; Sun S; Wang Q; Li C; Zhang X; Zhao A
BMC Pregnancy Childbirth; 2021 Oct; 21(1):683. PubMed ID: 34620101
[TBL] [Abstract][Full Text] [Related]
16. Thromboelastometry versus free-oscillation rheometry and enoxaparin versus tinzaparin: an in-vitro study comparing two viscoelastic haemostatic tests' dose-responses to two low molecular weight heparins at the time of withdrawing epidural catheters from ten patients after major surgery.
Thomas O; Larsson A; Tynngård N; Schött U
BMC Anesthesiol; 2015 Nov; 15():170. PubMed ID: 26603039
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology department.
Gylys KH
J Cardiovasc Nurs; 2001 Jul; 15(4):91-5. PubMed ID: 11419668
[TBL] [Abstract][Full Text] [Related]
18. Enoxaparin vs. nadroparin for venous thromboembolism prevention: too close to tell?
Tosetto A
J Thromb Haemost; 2006 Aug; 4(8):1691-2. PubMed ID: 16879210
[No Abstract] [Full Text] [Related]
19. Hepatocyte growth factor/activin A/follistatin system activation during hemodialysis with different low molecular weight heparins.
Rydzewska-Rosołowska A; Borawski J; Myśliwiec M
Ren Fail; 2009; 31(9):791-7. PubMed ID: 19925286
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of fondaparinux and bemiparin on angiogenic and vasculogenesis-like processes.
Da Pozzo E; Barsotti MC; Bendinelli S; Martelli A; Calderone V; Balbarini A; Martini C; Di Stefano R
Thromb Res; 2012 Sep; 130(3):e113-22. PubMed ID: 22497885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
